Cyclic vomiting syndrome: A narrative review and guide to management

Katja Kovacic1, B U K Li1

  • 1Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Medical College of Wisconsin, Milwaukee, WI, USA.

Headache
|February 23, 2021
PubMed

Insights

Cyclic vomiting syndrome (CVS) is a gut-brain disorder causing severe nausea and vomiting. Early diagnosis and migraine-focused treatments, including lifestyle changes, improve outcomes for affected children and adults.

Area of Science:

  • Gastroenterology
  • Neurology
  • Pediatrics

Background:

  • Cyclic vomiting syndrome (CVS) is a disabling gut-brain interaction disorder characterized by severe nausea and vomiting episodes.
  • Prevalence affects 1-2% of children, with a recent increase in adult diagnoses.

Purpose of the Study:

  • To provide a narrative review of pediatric and adult CVS literature.
  • To offer a management guide based on clinical experience.

Main Methods:

  • Literature review summarizing current knowledge on CVS.
  • Expert consensus diagnostic approach with limited testing.
  • Clinical experience guiding management strategies.

Main Results:

  • Diagnosis relies on expert consensus and exclusion tests (e.g., GI contrast study, ultrasound).
  • Metabolic/genetic conditions warrant exclusion in specific cases.
  • Migraine-equivalent CVS shares features with migraine; pathophysiology involves neuronal hyperexcitability and autonomic dysregulation.
  • Management includes lifestyle interventions and pharmacological therapies (abortive, supportive, prophylactic), with many responding to migraine-focused strategies.

Conclusions:

  • CVS is a functional brain-gut disorder often managed disjointedly.
  • Early recognition, evaluation, and management are crucial for improved outcomes.
  • Further research is needed on CVS natural history, neuroendocrine mechanisms, and its relation to migraine.
Abstract

Related Concept Videos

Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
1.9K
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
375
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
759
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
509
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
445
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
373